|
GS1 India Healthcare Conference 2026 to be held on Oct 9 in New Delhi, to focus on traceability, 2D barcodes & pharma export readiness
|
|
Shardul Nautiyal, Mumbai
September 23 , 2026
|
|
|
The GS1 India Healthcare Conference 2026 scheduled to be held on October 9, 2026 in New Delhi will bring together stakeholders from the pharmaceutical, medical devices, e-pharmacy and wider healthcare sectors to discuss developments in healthcare supply chains, product traceability and patient safety.
Organised by GS1 India, the conference is expected to provide a common platform for regulators, industry associations and healthcare companies to deliberate on the changing requirements for product identification, traceability and structured product data in India and international markets. The programme is particularly relevant for pharmaceutical manufacturers and exporters as global markets increasingly focus on supply-chain visibility, product authentication and regulatory compliance.
The invitation has been extended to Pharmaceuticals Export Promotion Council of India (Pharmexcil) and its member organisations, recognising the council's role in promoting India's pharmaceutical exports and supporting Indian pharmaceutical companies in accessing overseas markets. Pharmexcil director general (DG) Raja Bhanu has called for participation from the pharmaceutical export community, with members being invited to attend the conference at no cost.
For pharmaceutical exporters, the conference is expected to provide insights into evolving global requirements relating to product identification, traceability and structured product information. These areas have become increasingly important as regulators and supply-chain stakeholders seek greater visibility over medicines from manufacturing and distribution through to the point of delivery.
A key area of discussion will be the application of GS1 standards and two-dimensional, or 2D, barcodes in strengthening export readiness and supporting regulatory compliance. Standardised identification and machine-readable product information can help companies establish consistent data across supply-chain partners and markets, while also supporting the exchange of product information required by regulators and trading partners.
The conference will also examine how improved traceability can contribute to product authentication, more effective recalls and patient safety. For pharmaceutical companies operating across multiple markets, the ability to trace products through different stages of the supply chain can support faster identification of affected batches and improve coordination among manufacturers, distributors, regulators and other stakeholders.
Another focus will be interoperability and supply-chain visibility across global markets. Indian pharmaceutical exporters dealing with different regulatory and market requirements increasingly need systems that can exchange reliable product information across organisational and geographical boundaries. The adoption of common standards is intended to address this requirement by creating greater consistency in the identification and exchange of product data.
GS1 India has also highlighted the relevance of global harmonisation of standards for Indian pharmaceutical exporters. Greater alignment of identification and data standards across markets can help companies streamline operations, address compliance requirements and build greater trust among international supply-chain partners.
The conference comes at a time when traceability and digital identification are becoming important components of healthcare supply-chain management. Pharmaceutical companies are required to manage increasingly complex networks involving manufacturers, contract manufacturers, logistics providers, distributors, pharmacies and other healthcare stakeholders. Consistent product identification and data exchange can help improve visibility across these networks.
According to S. Swaminathan, CEO, GS1 India, the organisation is bringing together stakeholders from across the healthcare ecosystem through the conference to deliberate on developments shaping the future of healthcare supply chains and patient safety in India and globally. GS1 India's engagement with the pharmaceutical sector is centred on the use of standards to support identification, traceability and interoperability.
The conference is also expected to provide an opportunity for pharmaceutical exporters to understand how international standards can be integrated into their supply-chain processes and how 2D barcode-based systems can support product-level information requirements.
According to Pharmexcil DG, “Pharmexcil seeks support in encouraging participation from the pharmaceutical export community, particularly companies seeking to understand emerging international requirements and their implications for export operations. Pharmexcil members can register for the conference through the registration facility provided by GS1 India. For further information, members may contact S. Swaminathan, CEO, GS1 India, at the organisation's World Trade Center office in Nauroji Nagar, New Delhi.”
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|